Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
PaperCitations, authors & open-access status
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 34 citations, 2023 year and gold oa status.
34
Citations
2023
Year
gold
OA Status